Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality
Investigative Ophthalmology & Visual Science · 2024-11-26 · 65 (13) · 56
DOI: 10.1167/iovs.65.13.56 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2024-11-26. Written by Sabrina Wohlfart and 8 co-authors. Institution: The David J Apple Laboratory for Vision Research, Heidelberg, Germany. Major MEDLINE topics: Silicone Oils, Bevacizumab, Angiogenesis Inhibitors, Endotamponade. Cited 13 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To investigate the interaction of a common monoclonal antibody (bevacizumab) with silicone oils and vitreous substitute hydrogels.
Methods
Protein content (spectrophotometry) and bioactivity (ELISA) of bevacizumab were assessed after direct contact to silicone oil and vitreous substitute hydrogels up to 24 hours. To detect antibody aggregation, particle size was determined by dynamic light scattering. Changes in secondary protein structure were assessed using circular dichroism. Experiments were translated to another antibody, trastuzumab, because its bioactivity can be additionally quantified by its binding to the membrane of HER2-positive cells.
Results
The functionality of bevacizumab gradually decreased during exposure to silicone oils with only 30% of activity remaining after 24 hours. Although circular dichroism did not reveal structural changes, the particle size increased drastically, indicating antibody aggregation for both antibodies. Exposure to silicone oil strongly reduced binding of trastuzumab to HER2-positive cells. The addition of polysorbate, a common stabilizer for antibody formulations, dose-dependently prevented aggregation, with 62% aggregation observed at 0.04% polysorbate compared to only 10% aggregation at 0.5% polysorbate. No aggregation occurred after exposure to vitreous body replacement hydrogels.
Conclusions
Contact to silicone oils induces a major loss of functionality of bevacizumab and trastuzumab. This limits clinical use during silicone oil tamponade. The beneficial effect of adding polysorbate suggests that loss of solubilizer is a likely cause of aggregation. Hydrogels, alternatives for vitreous body replacement, do not impair antibody functionality.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- The David J Apple Laboratory for Vision Research, Heidelberg, Germany.
- Institute for Pharmacy and Molecular Biotechnology, Heidelberg University, Germany.
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
- University Eye Clinic Heidelberg, Heidelberg, Germany.
- Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Cite
APA
Wohlfart, S., Herth, J., Böhmann, M. B., Pander, G., Herbster, L., Mier, W., Auffarth, G. U., Uhl, P., & Hammer, M. (2024). Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality. Investigative Ophthalmology & Visual Science, 65(13), 56. https://doi.org/10.1167/iovs.65.13.56
Vancouver
Wohlfart S, Herth J, Böhmann MB, Pander G, Herbster L, Mier W, et al. Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality. Investigative Ophthalmology & Visual Science. 2024;65(13):56. doi:10.1167/iovs.65.13.56
BibTeX
@article{Wohlfart2024,
author = {Wohlfart, Sabrina and Herth, Jonathan and Böhmann, Manuel Ben and Pander, Giulia and Herbster, Lorenz and Mier, Walter and Auffarth, Gerd Uwe and Uhl, Philipp and Hammer, Maximilian},
title = {Exposure to Silicone Oil Endotamponades Induces VEGF Antibody Aggregation and Loss of Functionality},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
volume = {65},
number = {13},
pages = {56},
doi = {10.1167/iovs.65.13.56}
}
EUVIMED